Detalhe da pesquisa
1.
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Oncologist
; 2024 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38417095
2.
Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA.
Future Oncol
; 19(1): 37-47, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36662515
3.
Associations Between Medicaid Insurance, Biomarker Testing, and Outcomes in Patients With Advanced NSCLC.
J Natl Compr Canc Netw
; 20(5): 479-487.e2, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35545174
4.
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
Oncologist
; 24(9): 1209-1218, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30796156
5.
Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Oncologist
; 24(9): 1219-1228, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30808814
6.
Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database.
BMC Cancer
; 19(1): 548, 2019 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31174493
7.
Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis.
Value Health
; 18(2): 173-9, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25773552
8.
Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer.
Oncologist
; 19(8): 892-9, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25085899
9.
Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
Health Qual Life Outcomes
; 12: 102, 2014 Jul 03.
Artigo
Inglês
| MEDLINE | ID: mdl-24988902
10.
Estimating recurrences prevented and costs avoided with atezolizumab in early non-small cell lung cancer in the United States.
Cancer Med
; 12(6): 7450-7458, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36420712
11.
Cost-effectiveness of adjuvant atezolizumab for patients with stage II-IIIA PD-L1+ non-small-cell lung cancer.
Immunotherapy
; 15(8): 573-581, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37021770
12.
Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC.
JTO Clin Res Rep
; 4(4): 100487, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37007869
13.
ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.
Target Oncol
; 18(4): 571-583, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37341856
14.
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study.
Rheumatology (Oxford)
; 51(10): 1860-9, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22753773
15.
Real-world patterns of biomarker testing and targeted therapy in de novo metastatic non-small cell lung cancer patients in the US oncology network.
Cancer Treat Res Commun
; 31: 100522, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35189530
16.
Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer.
J Manag Care Spec Pharm
; 28(3): 305-314, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34913728
17.
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study.
BMC Musculoskelet Disord
; 12: 204, 2011 Sep 19.
Artigo
Inglês
| MEDLINE | ID: mdl-21929807
18.
Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.
JCO Oncol Pract
; 17(11): e1774-e1784, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34043456
19.
A RESPONSE TO "THE POTENTIAL LONG-TERM COMPARATIVE EFFECTIVENESS OF LAROTRECTINIB AND ENTRECTINIB FOR SECOND-LINE TREATMENT OF TRK FUSION-POSITIVE METASTATIC LUNG CANCER".
J Manag Care Spec Pharm
; 26(12): 1616-1617, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33251994
20.
Cost of cystectomy-related complications in patients with bladder cancer in the United States.
Curr Med Res Opin
; 36(7): 1177-1185, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32314606